Why the study?
The role of inflammation in acute coronary syndrome and the use of high-sensitivity C-reactive protein as a cardiovascular risk marker prompted updated guidelines and increased clinical interest.
This review discusses the use of high-sensitivity C-reactive protein as a nonlipid cardiovascular event risk marker and its implications for clinical practice.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Duffy et al. (2004) conducted a review in Cardiovascular events and myocardial infarction. High-sensitivity C-reactive protein (hs-CRP) was evaluated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: